The case of monkeypox in Serbia in 2022 - case report and literature review

  • Božidar P Pocevski Univerzitet u Beogradu, Medicinski fakultet
  • Marija Pocevski Pharmacy Institution Vranje, Kralja Stefana Prvovenčanog 43, Vranje https://orcid.org/0009-0007-3110-9964
  • Predrag Pocevski Health Center Vranje, General Hospital Vranje, Surgery Department Vranje, J. J. Lunge 1, Vranje https://orcid.org/0009-0002-9382-2013
  • Eleonora М Gvozdenović General Hospital MediGroup, Beograd
Keywords: monkeypox, mpox, epidemic, contagoius diseases, infectious diseases

Abstract


  Introduction. The Monkeypox virus (MPXV, also known as Mpox) is part of the Orthopoxvirus family, which includes some of the largest and most complex viruses studied in virology.
Case report. A 28-year-old male patient was examined in a general practitioner’s office. During the examination, skin lesions were found, including a panaritium on the small
phalanx of his left hand and two maculopapular lesions at the dorsal root of the penis. The physical examination indicated a viral infection, prompting the ordering of viral serology tests. The patient was advised to use symptomatic therapy, including
analgesics, antipyretics, anti-inflammatory medications, and vitamins. For the skin lesions, he was instructed to apply 70% alcohol, 3% hydrogen peroxide, and 10% povidone-iodine, as well as antiviral creams. The panaritium was drained, and local antibiotics were used. General symptoms resolved five days after starting therapy, and the skin lesions fully epithelized within 22 days from the onset.
Conclusion. General practitioners should continuously improve their skills to recognize less common pathologies, particularly those that are newly emerging. Satisfaction comes
from the ability to identify diseases and alleviate symptoms through dedicated knowledge, effort, and commitment. This is achieved by familiarizing oneself with the pathophysiology and clinical presentation of the relevant conditions.

References

Simpson K, Heymann D, Brown CS, Edmunds CS, Elsgaard J, Fine P, et al. Human monkeypox - After 40 years, an unintended consequence of smallpox eradication. Vaccine 2020;38(33):5077–81.

Barrett JW, McFadden G. Origin and Evolution of Poxviruses. In: Domingo E, Parrish CR, Holland JJ, editors. Origin and Evolution of Viruses. 2nd ed. London: Academic Press; 2008. p. 431–46.

Peiró-Mestres A, Fuertes I, Camprubí-Ferrer D, Marcos MA, Vilella A, Navarro M, et al. Frequent detection of monkeypox virus DNA in saliva, semen, and other clinical samples from 12 patients, Barcelona, Spain, May to June 2022. Euro Surveill 2022;27(28):2200503.

Joint ECDC-WHO Regional Office for Europe Monkeypox Surveillance Bulletin, 21 July 2022. Available from: https://cdn.who.int/media/docs/librariesprovider2/monkeypox/monkeypox_euro_ecdc_draft_jointreport_2022-07-20.pdf?sfvrsn=3666a22b_2&download=true Accessed August 15, 2024

Institut za javno zdravlje Srbije „Dr Milan Jovanović Batut“ [homepage on the Internet]. Infоrmаciја о prоglаšеnju еpidеmiје mајmunsкih bоginjа u višе zеmаljа zа јаvnоzdrаvstvеnu vаnrеdnu situаciјu оd mеđunаrоdnоg znаčаја оd 23. јulа 2022. gоdinе [updated 2022 July 26; cited 2022 August 9]. Available from: https://www.batut.org.rs/index.php?content=2412

European Centre for Disease Prevention and Control/WHO Regional Office for Europe. Mpox, Joint Epidemiological overview, 11 July 2024.

Martín-Delgado MC, Martín Sánchez FJ, Martínez-Sellés M, Molero García JM, Moreno Guillén S, Rodríguez-Artalejo FJ, et al. Monkeypox in humans: a new outbreak. Rev Esp Quimioter 2022;35(6):509–18.

McCollum AM, Damon IK. Human monkeypox [published correction appears in Clin Infect Dis 2014;58(12):1792]. Clin Infect Dis 2014;58(2):260–7.

Rizk JG, Lippi G, Henry BM, Forthal DN, Rizk Y. Prevention and Treatment of Monkeypox [published correction appears in Drugs 2022;82(12):1343]. Drugs 2022;82(9):957–63.

Reina J, Iglesias C. Vaccines against monkeypox. Med Clin (Engl Ed) 2023;160(7):305–9.

Rana J, Patel SK, Agrawal A, Channabasappa NK, Niranjan AK, Chandra Das B, et al. Mpox vaccination in global perspective: priorities and challenges. Ann Med Surg (Lond) 2023;85(5):2243–6.

Tomita N, Terada-Hirashima J, Uemura Y, Shimizu Y, Iwasaki H, Yano R, et al. An open-label, non-randomized study investigating the safety and efficacy of smallpox vaccine, LC16, as post-exposure prophylaxis for mpox. Hum Vaccin Immunother 2023;19(2):2242219.

Pischel L, Martini BA, Yu N, Cacesse D, Tracy M, Kharbanda K, et al. Vaccine effectiveness of 3rd generation mpox vaccines against mpox and disease severity: A systematic review and meta-analysis. Vaccine 2024;42(25):126053.

von Magnus P, Andersen EK, Petersen KB, Andersen AB. A pox-like disease in cynomolgus monkeys. Acta Pathologica Microbiologica Scandinavica 1959;46:156– 76.

Ladnyj ID, Ziegler P, Kima E. A human infection caused by monkeypox virus in Basankusu Territory, Democratic Republic of the Congo. Bull World Health Organ 1972;46(5):593–7.

Centers for Disease Control and Prevention. Monkeypox. Available from: https://www.cdc.gov/mpox/?CDC_AAref_Val=https://www.cdc.gov/poxvirus/mpox/index.html Accessed July 8, 2022

ECDC. Epidemiological update – Week 35/2024: Mpox due to monkeypox virus clade I. ECDC: Stockholm, 2024. Available from: https://www.ecdc.europa.eu/en/news-events/mpox-epidemiological-update-monkeypox-2-september-2024 Accessed September 10, 2024

MPOX: Five Ways Children are More at Risk from the Virus. Available from: https://prod-www.savethechildren.org/us/charity-stories/mpox-virus-ways-children-are-at-risk Accessed September 27, 2024

Published
2025/05/18
How to Cite
Pocevski, B. P., Pocevski, M., Pocevski, P., & GvozdenovićE. М. (2025). The case of monkeypox in Serbia in 2022 - case report and literature review. General Practice, 31(1-2), 22-31. https://doi.org/10.5937/opmed0-56117
Section
Original article